AI assistant
Sending…
BALCHEM CORP — Director's Dealing 2025
Feb 14, 2025
31041_dirs_2025-02-14_75254aff-ffed-4ecd-9404-c37136445d4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2025-02-12
Reporting Person: Boned Frederic (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-12 | Common Stock | A | 1580 | — | Acquired | 6730 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-12 | Stock Option | $159.18 | A | 5200 | Acquired | 2035-02-12 | Common Stock (5200) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 312 | Indirect |
Footnotes
F1: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Options vest 20% Year 1; 40% Year 2: and 40% Year 3.
More from BALCHEM CORP
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 20
Earnings Release
2026
Feb 20
Board/Management Information
2026
Feb 19